Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Psychotropic Medication Medicaid Children topic
No spam. Unsubscribe anytime.
Psychologist urges Medicaid 'medication guides' and database to track psychotropic prescriptions for children
Summary
Dr. Toby Watson, a clinical psychologist advising the Citizens Commission on Human Rights International, told the House Labor, Health & Social Services Committee that plain-language medication guides and a parent-reporting database should be required for psychotropic prescriptions to Medicaid-enrolled children so parents can recognize adverse reactions and ensure informed consent.
Dr. Toby Watson, a clinical psychologist who said he is an adviser to the Citizens Commission on Human Rights International (CCHR), briefed the House Labor, Health & Social Services Committee on a legislative proposal that would require distribution of plain-language medication guides for psychotropic drugs and establish a reporting mechanism for adverse drug responses among Medicaid-enrolled children.
Watson told the committee the proposal is intended to improve informed consent and to give parents and caregivers actionable information about side effects, risks and alternative interventions. "They created medication guides, which were very easy to read... they were meant to be, for parents and for people, like caregivers, to say, hey. This is important information," Watson said.
Watson cited national figures and research findings throughout his presentation. He said the U.S. spends more than $200 billion a year on mental-health services, that roughly one in six Americans takes at least one psychotropic medication, and that many patients who see a general practitioner for mental-health concerns leave with a prescription rather than a referral to a behavioral-health specialist. He also cited studies and analyses suggesting a link between some psychotropic medications and increased aggression, suicidal ideation and other serious adverse events.
Study citations presented to the committee included a review that, for a limited period of reporting, identified a small subset of medications that accounted for a large share of reported violent incidents; Watson said that analysis found 31 drugs responsible for roughly 79% of reported acts of violence in that sample and that the reports included homicides, assaults and many cases of homicidal ideation. He framed the proposal as a way to help parents identify possible medication-related adverse effects and to create a database to improve oversight for Medicaid, which pays for a substantial share of care for the affected children.
Legislative proposal and rationale: Watson said the brief asks lawmakers to require that prescribers give plain-language medication guides to parents and caregivers and that states maintain an accessible system for reporting suspected adverse drug reactions from psychotropic medications for Medicaid-enrolled children. He described the measures as intended to increase informed consent, make adverse-event reporting easier for families, and provide data to state Medicaid directors for quality improvement and oversight.
Questions and disclosures: Committee members asked about the group behind the brief and about where grant funding originated. Representative Yin asked about CCHR's relationship with the Church of Scientology; Watson responded that he had not researched current funding streams and that historically the church had been a funder but that CCHR is a separate nonprofit with a broader donor base. Representative Clauston asked whether model legislation has been enacted elsewhere; Watson said the proposal was pending in about 10 states and that CCHR was actively presenting it.
No committee action or vote followed the briefing. The committee chair noted the brief had been submitted to legislative services and would be uploaded for public review. Watson said he could provide additional state-level Medicaid prescription data on request.
